Our Company
ESG Management
Material Issues
ESG Performance
ESG Fact Book
Appendix
CEO Message
Company Overview
Hanmi Science Business Model
2025 Performance
Business Growth & Innovation
Lim Sung Ki Foundation
Hanmi Science ESG Management
2025 Materiality Assessment
Stakeholder Communication
Material Issue 1Strengthening Workplace Safety & Health
Material Issue 2-1Ensuring Customer Safety/Food
Material Issue 2-2Ensuring Customer Safety/Cosmetics
Material Issue 3Expanding Ethical & Compliance Management
Material Issue 4Information Security, Including Personal Information Protection
GOVERNANCE
Corporate Governance
Risk Management
ENVIRONMENTAL
Climate Change Response & Environmental Management
Biodiversity Conservation
SOCIAL
Human Rights Management
Human Capital
Welfare & Culture
Social Contribution
Financial Performance
EHS Management Performance
Human-oriented Management Performance
Reporting Framework
Reporting Scope & Verification
Status of Membership in Domestic and International Associations
ESG POLICIES
ESG Assessment
original hero image
Our Company
2025 Performance

2025 Performance

Business Highlight

Annual Performance Trend for the Last 5 Years
- Consolidated Basis

KRW 1,357 billion (2025 Sales) / KRW 138.7 billion (2025 Operating Profit)

Annual Performance Trend for the Last 5 Years
- Separate Basis

KRW 231.5 billion (2025 Sales) / KRW 56.5 billion (2025 Operating Profit)

2025 Annual Performance Details - Consolidated Basis

Category

Unit

Holding Company

Healthcare

Pharmaceutical
Wholesale

Other

Total

Technology Export Revenue

KRW 1M

23,062

-

-

-

23,062

Rental Income

2,345

1,103

-

-

3,448

Commission Income

17,229

2,957

53,339

3

73,528

Patent Royalties

9,272

-

-

-

9,272

Trademark Royalties

3,415

-

-

-

3,415

Product Sales

-

45,911

-

2,145

48,056

Merchandise Sales

-

74,849

1,083,252

624

1,158,725

Service Revenue

-

21,194

-

16,258

37,452

Total

55,323

146,014

1,136,591

19,030

1,356,958